Carteolol (ophthalmic) vs Dipyridamole

Interacting Drugs
Carteolol (ophthalmic)
vs
Dipyridamole
Security Level
Minor, Monitor Therapy
Mechanism
Dipyridamole: May enhance the bradycardic effect of Beta-Blockers.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Carteolol (ophthalmic) vs Dipyridamole